About the Author(s)


Patrice Djataou symbol
Laboratory of Systems Biology, Department of Biochemistry, Faculty of Science, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), University of Yaoundé I, Yaoundé, Cameroon

Department of Biochemistry, Faculty of Sciences, University of Yaoundé I, Yaoundé, Cameroon

Marceline D. Ngounoue symbol
Department of Biochemistry, Faculty of Sciences, University of Yaoundé I, Yaoundé, Cameroon

Georges Nguefack-Tsague symbol
Department of Public Health, Faculty of Medicine and Biomedical Sciences University of Yaoundé I, Yaoundé, Cameroon

Jean de Dieu Anoubissi symbol
National AIDS Control Committee, Yaoundé, Cameroon

Joséphine J.K. Kadji symbol
Laboratory of Systems Biology, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon

Tiga A. Aline symbol
Laboratory of Systems Biology, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon

Elise Elong symbol
Laboratory of Systems Biology, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon

Moussa Djaouda symbol
Department of Life and Earth Sciences, Higher Teachers’ Training College, University of Maroua, Maroua, Cameroon

Alexis Ndjolo symbol
Laboratory of Systems Biology, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon

Celine N. Nkenfou Email symbol
Laboratory of Systems Biology, ‘Chantal Biya’ International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaoundé, Cameroon

Department of Biological Sciences, Higher Teachers’ Training College, University of Yaoundé I, Yaoundé, Cameroon

Citation


Djataou P, Ngounoue MD, Nguefack-Tsague G, et al. Increased HIV and other sexually transmitted infections in two health facilities in Northern Cameroon between 2021 and 2022. J Public Health Africa. 2025;16(1), a690. https://doi.org/10.4102/jphia.v16i1.690

Original Research

Increased HIV and other sexually transmitted infections in two health facilities in Northern Cameroon between 2021 and 2022

Patrice Djataou, Marceline D. Ngounoue, Georges Nguefack-Tsague, Jean de Dieu Anoubissi, Joséphine J.K. Kadji, Tiga A. Aline, Elise Elong, Moussa Djaouda, Alexis Ndjolo, Celine N. Nkenfou

Received: 18 June 2024; Accepted: 14 Nov. 2024; Published: 25 Feb. 2025

Copyright: © 2025. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Human immunodeficiency viruses (HIV) and acquired immunodeficiency syndrome (AIDS) remain a global public health problem. Other sexually transmitted infections (STIs) are aggravating factors.

Aim: This study aimed to assess the prevalence and identify new cases of HIV and STIs, as well as their associated risk factors.

Setting: Political insecurity in the northern regions of Cameroon has led to population displacement, weakening an already fragile health system.

Methods: A cohort of 684 consenting participants from the north and far north were enrolled in 2021 and followed up in 2022. Socio-demographic variables and risk behaviours were collected. Anti-HIV Ab, hepatitis B surface antigen, Treponema pallidum haemagglutination tests were performed. The data were analysed using Epi Info 7.5.2. The associations between variables were evaluated using the Chi-square test with a 95% confidence interval.

Results: The new cases of HIV rate and overall prevalence were 1.63% (95% confidence interval [CI]: 0.83% – 2.41%) and 3.8% (95% CI: 2.01% – 3.97%), respectively. New HIV cases increased from 0.27% (2017, Demographic and Health Survey [DHS]) to 1.63%. The prevalence of syphilis and hepatitis B was 1.03% (95% CI: 0.98% – 1.09%) and 4.56% (95% CI: 4.51% – 4.66%), respectively. Factors associated with HIV included religion (p = 0.027), unprotected sex (p = 0.006), sex with a sex worker (p = 0.00009), and co-infection with syphilis and hepatitis B (p = 0.033). New HIV infections may also be associated with population displacement.

Conclusion: HIV infection, syphilis and hepatitis B are on the rise in the Northern Cameroon.

Contribution: Future HIV prevention strategies should consider population displacement and HIV-associated infections such as hepatitis B and syphilis in order to secure achievements in HIV programme and further curb the burden of these infections in the country.

Keywords: HIV; prevalence; new infection cases; hepatitis B; syphilis; insecurity; Northern Cameroon.

Introduction

In 2020, there were still 1.3 million new human immunodeficiency virus (HIV) infections, despite considerable efforts to reverse the trend. The total number of people living with HIV worldwide was 37.7 million, with 20.6 million in Africa.1 There is currently no vaccine or curative treatment for HIV or acquired immunodeficiency syndrome (AIDS). Control of the pandemic still relies on prevention and surveillance. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 strategic plan projected for 2025,2 95% of people living with HIV should know their HIV status, 95% of all HIV-infected people tested should receive sustained antiretroviral therapy, and 95% of people receiving antiretroviral therapy should have sustained viral load suppression. Challenges remain in achieving all the three targets. Monitoring new infections is key to achieve the first target. This includes frequent and repeated HIV testing of negative individuals and identification of associated risk factors. Cameroon is one of the hardest-hit countries in sub-Saharan Africa with localised and generalised epidemics.3 Although overall HIV prevalence among adults continues to decline, from 5.4% in 20044 to 4.3% in 2011,5 3.4% in 20176 and most recently 2.7% in 2018,7 continued surveillance is recommended. The data collected show that prevalence is not evenly distributed across regions. This is related to socio-cultural parameters such as religion, occupation, sexual behaviour, neighbourhood, traditions, standard of living, political security and the associated influx of refugees, or the strength of the health system.8,9,10 According to a World Bank report, 56% of poverty in Cameroon occurs in the northern regions alone, where Islam is one of the main religions. Human immunodeficiency virus prevalence is lowest in the north and far north regions of Cameroon (1.6% and 1.5%, respectively). In recent years, the terrorist group Boko Haram has established itself in the far north region of Cameroon. The aforementioned security problems have led to a significant influx of refugees and population displacement in the northern part of the country, which is threatening the health system in this zone. These disruptions could have an impact on HIV transmission in Northern Cameroon. We are investigating the reasons for this low prevalence in order to develop new HIV prevention strategies in conflict zones. Under these circumstances, this study aimed to assess the prevalence, and identify new cases of HIV and sexually transmitted infections (STIs), as well as their associated risk factors, in order to inform the development of more effective surveillance strategies for the epidemic.11

Research methods and design

Study design

We selected two of the most accessible hospitals in the north and far north regions of Cameroon as our research sites.

The study was conducted at the main entry points of the regional hospitals of Garoua and Maroua, located in the north and far north regions of Cameroon, respectively. The participants were tested at the outset of the study and again 1 year later, with a 12-month interval between tests (four HIV serologic windows [June 2021 – May 2022]). The minimum sample size was calculated using the following formula, which allows for a margin of error of 5%.12 Given the low prevalence of HIV in the northern regions of Cameroon, we employed the Epi Info 7.2 software to calculate the size of the population, taking into account the following criteria: the initial population size was considerable, with 50% of cases, an acceptable margin of error of 5%, a power of 80% and a confidence level of 95%. The data yielded 663 participants. Accounting for a loss to follow-up of approximately 3.2% or 21 additional participants, the total number of participants in the study was 684:

P denotes the prevalence of HIV infection in north and far north, which is under 5%; Zα/2, value of the fractile of the normal distribution at 5% = 1.96; d, degree of precision = 2%; the calculated size is N = 663 participants.

Taking into account a loss to follow-up of 3.2% (21 participants), the minimum sample size was set at 684 participants.

The study included individuals aged 18–70 years of both sexes who had lived in the north and far north regions for at least 5 years and who came to the hospital for work, medical consultations, or as visitors.

Sampling
Inclusion criteria

The study population comprised individuals aged between 18 years and 70 years, of both sexes, presenting at the hospital during the study period. Additionally, the study population included individuals who had resided in the north and far north regions for a minimum of 10 years.

Exclusion criteria

The exclusion criteria included the presence of any pathology (e.g., leukaemia) that would contraindicate a blood draw.

Recruitment was conducted in two phases. Phase 1 (Year 1) ran from 15 June 2021 to 13 August 2021, and Phase 2 (Year 2) ran from 30 May 2022 to 15 July 2022. During the first year of the study, 684 participants were enrolled and 5 mL of blood was drawn for the following tests: HIV1/2, hepatitis B surface antigen (HBsAg) and TPHA (Treponema pallidum haemagglutination assay). These STIs are known to exacerbate HIV infection or facilitate its transmission.

Socio-demographic data were obtained through the administration of a pre-tested questionnaire. Furthermore, the questionnaire encompassed data pertaining to population movements and the settlement of new individuals within the surrounding neighbourhoods.

For HIV1/2, the rapid diagnostic test was performed according to the national algorithm, using Determine Alere HIV1/2 Strips (Abbott Diagnostics Medical Co., Ltd. 357 Matsuhidai, Matsudo-shi Chiba, Japan) and confirmed using KHB (Shanghai Kehua Bio-engineering Co., Ltd.; www.skhb.com) tests according to the manufacturer’s instructions. Hepatitis B surface antigen test was performed using Fortress Diagnostic’s HBsAg rapid screening tests and confirmed using HBsAg CYPRESS diagnostics ELISA kits (Cypress Diagnostics: Langdrop, Belgium; www.diagnostics.be), according to the manufacturer’s instructions. Syphilis test (TPHA) was performed by SD BIOLINE Syphilis tests and confirmed by ELISA Bio-Rad (Bio-Rad 3, Marnes-la-coquette-France), according to the manufacturer’s procedures.

In the second year of the study, 676 of the 684 participants who had been enrolled in the first year were retested. Six participants were unable to reach the study site and two others had died. Individuals who tested positive in the initial assessment were not subjected to a second examination. The Chi-squared test was employed to ascertain whether the observed prevalence rates were consistent with the known prevalence rates. Additionally, new cases of infection were compared with the national incidence, and socio-cultural and sexual risk factors were analysed. Values with a p-value less than 0.05 were considered statistically significant.

Ethical considerations

Ethical clearance to conduct this study was obtained from the National Ethics Committee for Human Health in Cameroon (No. 2021/06/85/CE/CNERSHSP). All participants who were recruited consented to participate in the study and provided a written informed consent form.

Results

Socio-demographic characteristics of the study population

A total of 684 participants were enrolled. The mean age of participants was 31.4 ± 2.4 years, with a standard deviation of 12 ± 1.5 years. The age group most represented was that comprising individuals between the ages of 18 years and 35 years, which constituted 62.33% of the total number of participants. The female cohort constituted 47.37% (n = 324/684) of the study population, in comparison to 52.6% (n = 360/684) of the male cohort. The mean age at which the 684 participants engaged in sexual intercourse for the first time was 19.66 years, with a standard deviation of 3.7 years. The minimum age was 12 years and the maximum age was 32 years. A total of 15.6% of the participants disclosed a history of sexually transmitted infection, including cases of syphilis (n = 41), gonorrhoea (n = 37), and chlamydia (n = 12). For a comprehensive overview of the data, please refer to Table 1. A total of 547 participants (80% of the total number surveyed) indicated that population movement had occurred in their neighbourhood over the past 3 years.

TABLE 1: Socio-demographic and clinical characteristics of the study population.
Prevalence and new cases of HIV, hepatitis B and syphilis in the study population

The prevalence of HIV, syphilis, and hepatitis B infections in the initial phase of the study was 1.90%, 4.09%, and 0.146%, respectively.

The incidence of new cases of HIV, hepatitis B, and syphilis infections was found to be 1.62% (95% confidence interval [CI]: 0.83–2.41), 4.72% (95% CI: 4.51–4.660), and 1.03% (95% CI: 0.98–1.09), respectively (Table 2). In comparison with the incidence of HIV in Cameroon, there has been a notable increase in new cases of infection (p = 0.007).

TABLE 2: Prevalence and new cases of HIV, hepatitis B, and syphilis in the study population.

The global incidence of HIV-hepatitis B and HIV-syphilis co-infection rates was 0.29% (95% CI: 0.18–0.41), and 0.15% (95% CI: 0.08–0.24), respectively. In the initial phase of the study, there were no cases of HIV-syphilis or HIV-hepatitis co-infection.

New cases of HIV infection detected were referred to the treatment centre in the region as per test and treatment strategies. Cases of new syphilis infections were immediately managed by the medical staff. Hepatitis B cases were referred to the ‘Centre Pasteur Annexe de Garoua’ for follow-up.

Risk factors associated with HIV infection

As shown in Table 3, the socio-behavioural factors associated with HIV acquisition were religion (Muslim, p = 0.027), unprotected sexual intercourse with a new partner (p = 0.006), and sexual relationships with sex workers (p = 0.00009).

TABLE 3: Risk factors associated with HIV infection.

Discussion

The study revealed an overall HIV and/or AIDS prevalence of 3.5% (2022), which was statistically distinct (p = 0.008) from the 1.55% documented by the Demographic and Health Survey (DHS) in 2018 in these two regions. In addition, the incidence rate of new cases was found to be significantly elevated (p = 0.007) in comparison to the 0.24% reported by the DHS in 2018 in Cameroon. This high prevalence rate may be attributed to the study setting as it was conducted in hospitals. The study found that new cases of HIV infection was 1.63%, which is significantly higher than the national incidence in Cameroon (0.24% according to DHS in 2018) with a p-value of less than 0.001. The statistical analysis revealed that factors such as religion, engagement in sex work, unprotected sex with a new partner, and the presence of STIs (syphilis and hepatitis B infections) were significantly associated with this high incidence. These findings are consistent with previous studies conducted among pregnant women or blood donors.13,14,15,16 Recent studies indicate a re-emergence of syphilis17,18,19 (1.02% new cases with an overall prevalence of 1.16%). Syphilis is known to promote the acquisition of HIV through the sexual lesions it causes.18,19,20,21

The deficiencies in the health system and prevailing insecurity in these regions have the potential to exacerbate pre-existing health issues. The recent influx of refugees has further compounded these challenges, leading to increased promiscuity, poverty, and unsanitary conditions. A number of studies have focused on the impact of armed conflict and displaced populations, demonstrating the adverse effects of political instability on the HIV and/or AIDS response.22 Although reviews indicate insufficient evidence to conclude that armed conflict is associated with an increase in prevalence,23 our study, conducted on a smaller population, shows an increase in prevalence in the specific context of Cameroon. In Cameroon, the ratio of health centres to the population is below the World Health Organization (WHO) recommended standard of one centre per 10 000 inhabitants, with only one centre per 20 000 inhabitants.11 This ratio declines further when considering the population of displaced neighbours, which has a negative impact on the quality of healthcare.

Ankouane et al. conducted a study on blood donors at the Yaoundé Central Hospital and found a prevalence of syphilis to be 0.2%.15 Newman and colleagues reported a worldwide prevalence of treponemal infection to be 0.5% – 0.6%.24 Recent research suggests that syphilis is re-emerging globally.21,25,26,27,28 Treponemal infection has the potential to act synergistically with HIV, increasing infectivity.18,19,20,29,30 The reappearance of syphilis in regions with lower HIV prevalence in Cameroon is a cause for concern, as it suggests the possibility of new HIV infections.

The prevalence and incidence of hepatitis B were 6.28% and 4.72%, respectively. These data illustrate a reciprocal correlation between the occurrence of hepatitis B infection and HIV infection, as evidenced by the prevalence and incidence studies conducted in co-infected individuals.31 The dissemination of the disease can be attributed to socio-cultural and lifestyle factors, including the practice of eating in a common dish and the utilisation of shared needles for scarification. Furthermore, there is a notable reluctance to seek treatment, which has led to an increase in new infection cases caused by the hepatitis B virus.32 In order to prevent the spread of hepatitis B, it is essential that community education and counselling programmes be implemented. The age group with the highest infection rate was between 25 years and 35 years of age, which corresponds to the most sexually active age group, as evidenced by other national and international data.2,33,34 A higher infection rate was observed among Muslims (n = 8; p = 0.027) compared to Christians. These results align with those reported in a study conducted by Mboppi et al. in 2014 in Meyomessala, South Cameroon.8 The study demonstrated that the Islamic religion is more tolerant of polygamy and the establishment of a patriarchal society. In a recent epidemiological and observational study conducted in Zambia, Nesamoney and colleagues identified religion35 and ethnicity/race,36 particularly associated practices, as significant factors in understanding the trend of HIV infection among Muslims. One of the socio-behavioural factors that facilitates HIV transmission is having had unprotected sex (n = 5; p = 0.0009). A review of previous incidence and prevalence studies25,37,38,39 have demonstrated that factors that exacerbate infection or the occurrence of infection are typically associated with an individual’s sexual behaviour within society. Those engaged in sex work represent a subset of the population that is persistently exposed and vulnerable to infection,25,36,40 as well as individuals with disabilities.41 It can be reasonably deduced that individuals who engage in sexual activity with this group are at risk of contracting HIV and other STIs. The study demonstrated that men who engaged in sexual activity with female sex workers (n = 9) were more likely to contract HIV than those who did not associate with these women (n = 5; p < 0.0001).

In a recent WHO release, key facts on HIV were presented. These facts indicate that HIV continues to be transmitted in every country in the world. Furthermore, some countries have reported an upward trend in new infections after a period of decline (https://www.who.int/news-room/fact-sheets/detail/hiv-aids 13 july 2023.)

It must be acknowledged that the limitations of this study are because of the relatively small size of the population under investigation. Nevertheless, the observed trend is a cause for concern.

The participants were recruited from regional hospitals in the north and far north, which may introduce bias and potentially inflate the infection rate, as found in the study.

Although the study period of 12 months is relatively short in comparison to other multi-year impact studies,42,43,44 the observed trend is nevertheless significant.

Conclusion

This study indicates that HIV infection is on the rise in the north and far north regions of Cameroon, primarily because of the rising prevalence of syphilis and hepatitis B infections, in addition to religious beliefs and risky sexual behaviour. Moreover, the findings were obtained in a context of heightened insecurity and population displacement. This trend may be replicated in analogous contexts in other countries where political instability is a pervasive issue. It is therefore of the utmost importance to prioritise the control of the epidemic through the prevention of new infections in order to sustain the achievements made thus far.

Acknowledgements

The authors would like to acknowledge the contribution of all participants who have taken part in this study.

Competing interests

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Authors’ contributions

P.D. was involved in conception, study design, patient enrolment, laboratory and data analyses, and article preparation. M.D.N. performed conception, study design, patient enrolment, data analysis, and article revision. G.N.-T. was responsible for study design, data analysis and interpretation. J.d.D.A. contributed to study design, data analysis and interpretation. J.J.K.K., T.A.A. and E.E. conducted sample collection and samples analysis. M.D. was involved in article revision. A.N. was responsible for conception and study design. C.N.N. carried out conception, study design, data analysis, and article revision. All authors read, revised and approved the final version of the article.

Funding information

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Data availability

All data collected are presented in the article.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency, or that of the publisher. The authors are responsible for this article’s results, findings, and content.

References

  1. UNAIDS. Fiche d’information – Dernières statistiques sur l’état de l’épidémie de sida [homepage on the Internet]. 2022 [cited 2023 Aug 08]. Available from: https://www.unaids.org/fr/resources/fact-sheet
  2. UNAIDS. Global HIV & AIDS statistics — Fact sheet [homepage on the Internet]. UNAIDS; 2024 [cited 2023 Mar]. Available from: https://www.unaids.org/en/resources/fact-sheet
  3. Cameroon – UNAIDS [homepage on the Internet]. Project: Cameroon – UNAIDS country envelope (2022–2023) details. Core Data Portal. 2022 [cited 2024 June 17]. Available from: https://core.unesco.org/fr/project/257GLO1045.5.3
  4. Cameroon DHS survey. 2004 Cameroon demographic and health survey demographic [homepage on the Internet]. 2004 [cited 2023 Mar]. Available from: https://dhsprogram.com/pubs/pdf/HF2/Cameroon_HIV_factsheet.pdf
  5. Cameroon Demographic and Health Survey and Multiple Indicators Cluster Surveys (DHS-MICS). HIV prevalence in Cameroon: Findings from the 2011 DHS–MICS [homepage on the Internet]. 2011 [cited 2023 Mar]. Available from: https://www.dhsprogram.com/pubs/pdf/HF42/HF42.pdf
  6. CAMPHIA. Évaluation de l’impact du vih dans la population au Cameroun camphia 2017 [homepage on the Internet]. 2017 [cited 2023 Mar]. Available from: https://phia.icap.columbia.edu/wp-content/uploads/2020/06/CAMPHIA-Summary-Sheet-FR_ARV-Adjusted_Mar2020.pdf
  7. DHS Cameroon. 2018 Demographic and Health Survey Cameroon [homepage on the Internet]. 2018 [cited 2023 Mar]. Available from: https://dhsprogram.com/pubs/pdf/OF44/OF44.HIV.E.pdf
  8. Mbopi-Keou FX, Nguefack-Tsague G, Mireille GC, Abo’o Abessolo S, Angwafo Iii F, Muna W. Facteurs de risque de l’infection par le VIH dans le district de santé de Meyomessala au Cameroun. Pan Afr Med J. 2014;18:61. https://doi.org/10.11604/pamj.2014.18.161.3238
  9. Sandie AB, Tchatchueng Mbougua JB, Nlend AEN, et al. Hot-spots of HIV infection in Cameroon: A spatial analysis based on demographic and health surveys data. BMC Infect Dis. 2022;22(1):334. https://doi.org/10.1186/s12879-022-07306-5
  10. Mpabe Bodjongo MJ. Pauvreté, croyances sur la transmission du VIH-SIDA et écart du recours au test de dépistage du VIH-SIDA chez les femmes entre zones rurales et urbaines au Cameroun. J Gest Déconomie Santé. 2021;2021(3–4):158–182.
  11. BANQUE MONDIALE. World Bank [homepage on the Internet]. 2023 [cited 2023 May 17]. Cameroun – Vue d’ensemble. Available from: https://www.banquemondiale.org/fr/country/cameroon/overview
  12. Lwanga SK, Lemeshow S, Organization WH. Détermination de la taille d’ un échantillon dans les études sanométriques: Manuel pratique [homepage on the Internet]. Organisation mondiale de la Santé; 1991 [cited 2023 May 18]. Available from: https://apps.who.int/iris/handle/10665/36881
  13. Dionne-Odom J, Mbah R, Rembert NJ, et al. Hepatitis B, HIV, and syphilis seroprevalence in pregnant women and blood donors in Cameroon. Infect Dis Obstet Gynecol. 2016;2016(1):e4359401. https://doi.org/10.1155/2016/4359401
  14. Kumari S, Pandey P, Setya D, Singh DK. HIV, Hepatitis B and C viruses and syphilis coinfection among blood donors in hospital settings [homepage on the Internet]. BSH Annual Scientific meeting 2022. 62nd Annual Scientific Meeting 3-5 April 2022, Manchester Central [cited Feb 2022]; p. 1. Available from: https://www.postersessiononline.eu/173580348_eu/congresos/BSH2022/aula/-PO_47_BSH2022.pdf
  15. Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR, Biwolé Sida M. Séroprévalence des virus des hépatites B et C, du VIH-1/2 et de la syphilis chez les donneurs de sang de l’hôpital central de Yaoundé, région du centre, Cameroun. Transfus Clin Biol. 2016;23(2):72–77. https://doi.org/10.1016/j.tracli.2015.11.008
  16. Melku M, Kebede A, Addis Z. Magnitude of HIV and syphilis seroprevalence among pregnant women in Gondar, Northwest Ethiopia: A cross-sectional study. HIVAIDS – Res Palliat Care. 2015;7:175–182. https://doi.org/10.2147/HIV.S81481
  17. Mattei PL, Beachkofsky TM, Gilson RT, Wisco OJ. Syphilis: A reemerging infection. Am Fam Physician. 2012;86(5):433–440.
  18. Nkenfou C, Njolle NE, Nguefeu C, et al. P50 – Syphilis is on the rise among pregnant women in Cameroon. J Virus Erad. 2018;4(suppl 1):36–37. https://doi.org/10.1016/S2055-6640(20)30432-5
  19. Kengne-Nde C, Anoubissi JDD, Loni-Ekali G, et al. Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis. PLoS One. 2020;15(11):e0241999. https://doi.org/10.1371/journal.pone.0241999
  20. Karp G, Schlaeffer F, Jotkowitz A, Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med. 2009;20(1):9–13. https://doi.org/10.1016/j.ejim.2008.04.002
  21. Kenyon C, Osbak KK, Crucitti T, Kestens L. The immunological response to syphilis differs by HIV status; a prospective observational cohort study. BMC Infect Dis. 2017;17(1):111. https://doi.org/10.1186/s12879-017-2201-7
  22. Kumogola Y, Slaymaker E, Zaba B, et al. Trends in HIV & syphilis prevalence and correlates of HIV infection: Results from cross-sectional surveys among women attending ante-natal clinics in Northern Tanzania. BMC Public Health. 2010;10(1):553. https://doi.org/10.1186/1471-2458-10-553
  23. Mekolle JE, Tshimwanga KE, Ongeh NJ et al. Political instability and HIV/AIDS response in the south west and north west regions of Cameroon: A qualitative study. BMC Public Health. 2023;23(1):2155. https://doi.org/10.1186/s12889-023-16994-w
  24. Newman L, Rowley J, Hoorn SV, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304. https://doi.org/10.1371/journal.pone.0143304
  25. Mishra D, O’ Laughlin K, Spiegel P. A systematic review evaluating HIV prevalence among conflict-affected populations, 2005–2020. Aids Rev. 2021;23(3):6530. https://doi.org/10.24875/AIDSRev.200001311
  26. Inungu JN, Kandala BFN, Atungale AM. Prevalence of HIV and syphilis and related risk behaviors among female sex workers in the Democratic Republic of the Congo. Eur J Environ Public Health. 2022;6(2):em0114. https://doi.org/10.21601/ejeph/12179
  27. Aho J, Lybeck C, Tetteh A, et al. Rising syphilis rates in Canada, 2011–2020. Can Commun Dis Rep. 2022;47(2–3):52–60. https://doi.org/10.14745/ccdr.v48i23a01
  28. Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. N Engl J Med. 2020;382(9):845–854. https://doi.org/10.1056/NEJMra1901593
  29. Bonett S, Tam V, Singapur A, Min J, Koenig HC, Wood SM. Incidence of syphilis infection and syphilis-related care utilization among adolescents and young adults living with HIV: Int J STD AIDS. 2021. 33(2):136–143. https://doi.org/10.1177/09564624211048774
  30. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections: AIDS. 2004;18(15):2075–2079. https://doi.org/10.1097/00002030-200410210-00012
  31. Lynn W, Lightman S. Syphilis and HIV: A dangerous combination. Lancet Infect Dis. 2004;4(7):456–466. https://doi.org/10.1016/S1473-3099(04)01061-8
  32. Seyoum E, Demissie M, Worku A, Mihret A, Abdissa A, Berhane Y. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: A retrospective cohort study. BMC Public Health. 2022;22(1):644. https://doi.org/10.1186/s12889-022-13025-y
  33. Aimé WM, Stone MR. Compiliance thérapeutique chez le patient camerounais souffrant de l’hépatite B. Int Multiling J Sci Technol. 2022;7(5):4904–4912.
  34. Sidaction. Fiche d’information – Dernières statistiques sur l’état de l’épidémie de sida [homepage on the Internet]. 2020 [cited 2022 June 23]. Available from: https://www.sidaction.org/donnees-epidemiologiques-vihsida-monde-2020
  35. Hoffman S, Zhang A, Nguyen N, et al. Incident HIV infection among young men associated with female sexual partner types identified through latent class analysis, Rakai, Uganda. J Acquir Immune Defic Syndr. 2022;90(2):124–131. https://doi.org/10.1097/QAI.0000000000002928
  36. Nesamoney SN, Mejía-Guevara I, Weber AM, Cislaghi B, Mbizvo MT, Darmstadt GL. The taboo gap: Implications for adolescent risk of HIV infection. Lancet Child Adolesc Health. 2022;6(3):140–142. https://doi.org/10.1016/S2352-4642(21)00398-9
  37. Garofalo R, Hotton AL, Kuhns LM, Gratzer B, Mustanski B. Incidence of HIV infection and sexually transmitted infections and related risk factors among very young men who have sex with men. J Acquir Immune Defic Syndr. 2016;72(1):79–86. https://doi.org/10.1097/QAI.0000000000000933
  38. Gregson S, Garnett GP, Nyamukapa CA, et al. HIV decline associated with behavior change in Eastern Zimbabwe. Science. 2006;311(5761):664–666. https://doi.org/10.1126/science.1121054
  39. Young PW, Musingila P, Kingwara L, et al. HIV incidence, recent HIV infection, and associated factors, Kenya, 2007–2018. Lancet; 2022. https://doi.org/10.2139/ssrn.4049636
  40. Jose JEdC, Sakboonyarat B, Mungthin M, Nelson KE, Rangsin R. Rising prevalence of HIV infection and associated risk factors among young Thai Men in 2018. Sci Rep. 2021;11(1):1–10. https://doi.org/10.1038/s41598-021-87474-7
  41. Alemu GH, Gidebo DD, Ali MM. Magnitude of HIV infection and associated factors among female sex workers at Hawassa, Ethiopia. Ethiop J Health Sci. 2022;32(2):261. https://doi.org/10.4314/ejhs.v32i2.6
  42. Cisse K, Ouedraogo HG, Compaore TR, et al. Prevalence and factors associated with HIV infection among people with disabilities in Mali. AIDS Care. 2022;34(suppl 1):52–59. https://doi.org/10.1080/09540121.2022.2049195
  43. Mutagoma M, Balisanga H, Remera E, et al. Ten-year trends of syphilis in sero-surveillance of pregnant women in Rwanda and correlates of syphilis-HIV co-infection. Int J STD AIDS. 2017;28(1):45–53. https://doi.org/10.1177/0956462415624058
  44. Huang J, Wu H, Lin S, et al. Spatial–temporal analysis of HIV/AIDS and syphilis in mainland China from 2007 to 2017. J Med Virol. 2022;94(7):3328–3337. https://doi.org/10.1002/jmv.27725


Crossref Citations

No related citations found.